Document is current
Any future updates will be listed below
-
Authors
Devilée, Lynn A. C. https://orcid.org/0000-0002-6176-4392
Salama, Abou bakr M. https://orcid.org/0000-0002-2241-3792
Miller, Jessica M.
Reid, Janice D.
Ou, Qinghui
Baraka, Nourhan M.
Abou Farraj, Kamal
Jamal, Madiha
Nong, Yibing https://orcid.org/0000-0001-7934-7821
Rosengart, Todd K.
Andres, Douglas
Satin, Jonathan
Mohamed, Tamer M. A.
Hudson, James E. https://orcid.org/0000-0003-0832-9356
Abouleisa, Riham R. E. https://orcid.org/0000-0001-8883-068X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL147921)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (P30GM127607)
American Heart Association (16SDG29950012)
Snow Medical fellowship, Australlia
- License Information
-
More Information
Article History
Received: 3 November 2023
Accepted: 1 January 2025
First Online: 11 January 2025
Competing interests
: T.M.A.M holds equities in Tenaya Therapeutics. T.M.A.M. is a co-inventor on pending patents that relate to heart slice culture. J.E.H. is listed as a co-inventor on pending patents that relate to cardiac organoid maturation and cardiac regeneration therapeutics. J.E.H. is a co-inventor on licensed patents relating to engineered heart muscle. J.E.H. is a co-founder, scientific advisor, and stockholder in Dynamics. The other authors report no disclosures.
